ClinicalMetric / Countries / Finland / prostate cancer
← 🇫🇮 Finland Trials
🇫🇮 Finland Country × Condition

prostate cancer Clinical Trials in Finland

Active clinical trials for prostate cancer with research sites in Finland. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 3 // Recruiting: 3 Phases: Phase 4 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇫🇮 Finland

Active Trials in Finland (3)

NCT07740239
Recruiting

A COhort Study on Factors Leading to Vulnerability in Adult Patients With Serious Medical cOnditionS: the COSMOS-I Trial

Enrollment
2,050 pts
Country
🇫🇮 Finland
Tampere University Hospital
View Trial →
NCT06116851
Recruiting

Prostate Metabolism, Cancer Risk and Gut Microbiota

Enrollment
300 pts
Country
🇫🇮 Finland
Turku University Hospital
View Trial →
NCT06001619 Phase 4
Recruiting

Prostate Medication, Metabolism and Gut Microbiota

Enrollment
100 pts
Country
🇫🇮 Finland
Turku University Hospital
View Trial →

Frequently Asked Questions

How many prostate cancer clinical trials are active in Finland?
There are currently 3 active clinical trials for prostate cancer with sites in Finland, of which 3 are actively recruiting patients.
How can I join a prostate cancer clinical trial in Finland?
To join a prostate cancer clinical trial in Finland, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Finland directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are prostate cancer trials in Finland?
Active prostate cancer trials in Finland span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Finland Trials → Global prostate cancer Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology